Получите доступ ко всем премиум-функциям лучшего инструмента для анализа акций

JASPER, Ind.--(BUSINESS WIRE)--Kimball Electronics, Inc. (Nasdaq: KE) today announced the release of its 2025 Guiding Principles Report, which includes the company's annual sustainability disclosures. Themed “Building Tomorrow, Together,” the Report outlines progress on environmental, social, and governance (ESG) initiatives and reflects the company's continued focus on the issues that matter most—where it can make a meaningful and lasting difference for people and the environment, while suppor.

JASPER, Ind.--(BUSINESS WIRE)--Kimball Electronics, Inc. (Nasdaq: KE) today announced its upcoming participation in multiple investor conferences in March 2026, including hosted fireside chats and one-on-one meetings with institutional investors. Cantor Global Technology & Industrial Growth Conference When: Wednesday, March 11, 2026 Location: New York Hilton Midtown, 1335 Avenue of the Americas, New York, NY 10019 Format: Fireside chat (in-person participation only) and one-on-one meetings.

Kimball Electronics, Inc. (KE) Q2 2026 Earnings Call Transcript

KE reports Q2 FY26 earnings in line with estimates as revenues decline year over year, while margins expand, and full-year sales guidance is raised.

Kimball Electronics (KE) came out with quarterly earnings of $0.28 per share, in line with the Zacks Consensus Estimate . This compares to earnings of $0.29 per share a year ago.

JASPER, Ind.--(BUSINESS WIRE)--Kimball Electronics, Inc. (Nasdaq: KE) today announced financial results for the second quarter ended December 31, 2025.                 Three Months Ended   Six Months Ended   December 31,   December 31, (Amounts in Thousands, except EPS)   2025       2024       2025       2024   Net Sales $ 341,280     $ 357,392     $ 706,883     $ 731,648   Operating Income $ 10,767     $ 8,230     $ 25,221     $ 17,345   Adjusted Operating Income (non-GAAP) $ 15,308     $ 13,3.

Weakness across the automotive and industrial segments is likely to have more than offset the benefits of strong performance at KE's medical division in Q2.